Kazemi Azar, Gharib Masoumeh, Mohamadian Roshan Nema, Taraz Jamshidi Shirin, Stögbauer Fabian, Eslami Saeid, Schüffler Peter J
Institute of General and Surgical Pathology, Technical University of Munich, 81675 Munich, Germany.
Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Diagnostics (Basel). 2023 Jul 11;13(14):2339. doi: 10.3390/diagnostics13142339.
To implement the new marker in clinical practice, reliability assessment, validation, and standardization of utilization must be applied. This study evaluated the reliability of tumor-infiltrating lymphocytes (TILs) and tumor-stroma ratio (TSR) assessment through conventional microscopy by comparing observers' estimations.
Intratumoral and tumor-front stromal TILs, and TSR, were assessed by three pathologists using 86 CRC HE slides. TSR and TILs were categorized using one and four different proposed cutoff systems, respectively, and agreement was assessed using the intraclass coefficient (ICC) and Cohen's kappa statistics. Pairwise evaluation of agreement was performed using the Fleiss kappa statistic and the concordance rate and it was visualized by Bland-Altman plots. To investigate the association between biomarkers and patient data, Pearson's correlation analysis was applied.
For the evaluation of intratumoral stromal TILs, ICC of 0.505 (95% CI: 0.35-0.64) was obtained, kappa values were in the range of 0.21 to 0.38, and concordance rates in the range of 0.61 to 0.72. For the evaluation of tumor-front TILs, ICC was 0.52 (95% CI: 0.32-0.67), the overall kappa value ranged from 0.24 to 0.30, and the concordance rate ranged from 0.66 to 0.72. For estimating the TSR, the ICC was 0.48 (95% CI: 0.35-0.60), the kappa value was 0.49 and the concordance rate was 0.76. We observed a significant correlation between tumor grade and the median of TSR (0.29 (95% CI: 0.032-0.51), -value = 0.03).
The agreement between pathologists in estimating these markers corresponds to poor-to-moderate agreement; implementing immune scores in daily practice requires more concentration in inter-observer agreements.
为了在临床实践中应用新的标志物,必须进行可靠性评估、验证以及使用的标准化。本研究通过比较观察者的估计值,评估了通过传统显微镜评估肿瘤浸润淋巴细胞(TILs)和肿瘤间质比(TSR)的可靠性。
三位病理学家使用86张结直肠癌苏木精-伊红(HE)切片评估肿瘤内和肿瘤前沿的间质TILs以及TSR。TSR和TILs分别使用一种和四种不同的提议临界值系统进行分类,并使用组内相关系数(ICC)和科恩kappa统计量评估一致性。使用Fleiss kappa统计量和一致性率进行一致性的成对评估,并通过Bland-Altman图进行可视化。为了研究生物标志物与患者数据之间的关联,应用了Pearson相关分析。
对于肿瘤内间质TILs的评估,获得的ICC为0.505(95%置信区间:0.35 - 0.64),kappa值在0.21至0.38范围内,一致性率在0.61至0.72范围内。对于肿瘤前沿TILs的评估,ICC为0.52(95%置信区间:0.32 - 0.67),总体kappa值在0.24至0.30范围内,一致性率在0.66至0.72范围内。对于TSR的估计,ICC为0.48(95%置信区间:0.35 - 0.60),kappa值为0.49,一致性率为0.76。我们观察到肿瘤分级与TSR中位数之间存在显著相关性(0.29(95%置信区间:0.032 - 0.51),P值 = 0.03)。
病理学家在估计这些标志物方面的一致性对应于较差至中等程度的一致性;在日常实践中实施免疫评分需要更多关注观察者间的一致性。